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The antihistnminic (2).chlorphcniramine significantly reduced the progression of Ehrlich carcinoma when it was administered at 0.5 mg/mousclday 
from the third day on. after tumour inoculation. The ODC activity of tumour cells was diminislled by 70% on day 7 after tumour transplantation, 
when maximum ODC activity is detected in non-treated tumour growing ‘in viva’. Northern blot analysts indicated that the inhibitory effect of 
this I ,4-diamine takes place at a post-transcriptional level. Results obtained from serum-free cultured cells indicated that chlorpheniramine inhibits 
IIIC ODC synthesis rate. 
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1. INTRODUCTION 
Polyamines, putrcscine, spermidine and spermine are 
organic cations which play an important role in cell 
proliferation [I]. Ornithine decarboxylase activity 
(ODC, EC 4.1 .I. I?), the main regulatory step for pol- 
yamine biosynthesis, is induced by different growth 
stimuli at the transcriptional nd translational level [2- 
43. However, polyamines inhibit ODC expression at the 
translational level and/or by post-translational modifi- 
cations of the protein [5,6]. In addition, an ODC-inhib- 
itory protein named ‘antizyme’ is induced by poly- and 
diamines [7]. Actually, some non-natural diamines (i.e. 
1,3-diaminopropane, bis-ethyl-spermidine), have been 
described as polyamine analogs also inhibiting ODC 
induction at translational and post-translational level 
L&91. 
In 1989, Mates et al. [lo] added histamine and sero- 
tonin to the list of diamines controlling ODC activity. 
Both I,4-diamines were able to inhibit the short-term 
induction of ODC activity caused by ornithine in peri- 
fused Ehrlich carcinoma cells, showing a clear dose- 
response ffect. Recently, authors have reported that 
this effect can also be exerted by other non-natural 
amines which have some common structural character- 
istics: 1,4-diamine structure, N-N distance around 6 A, 
and at least one charge amino group [l 11; among these 
1 ,4-diamines, the histamine analog (kj-chlorpheniram- 
ine was able to inhibit by more than 90% the induction 
of ODC activity when Ehrlich tumour cells were peri- 
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fused in saline buffer supplemented with 0.5 mM orni- 
thine and 55 PM chlorpheniramine. 
In this report, the effect of (f)-chlorpheniramine on 
the ODC expression and tumour progression is studied. 
Results indicate that the presence of chlorpheniramine 
in cell cultures causes an inhibition of ‘de novo’ synthe- 
sis of the protein. ‘In vivo’ experiments resulted in a 
decrease of both ODC activity and tumour prolifera- 
tion. 
2. MATERIALS AND METHODS 
A hyperdiploid LcttrC strain of Ehrlich carcinomz was maintained 
as previously reported [121. For Fig. I, groups of 8 mice were inocu- 
lated with 5~10~ tumour cells and treated as dcscribcd in section 3. The 
animals’ weights were determined aily until dcntlz. To determine the 
total number of cells, ascitic fluid volumes, ODC activities and levels 
of ODC mRNAs. two groups of IB mice were inoculated with 5x10’ 
tumour cells; S animals ofeach group were daily injected i.p. with 0.3 
ml of 6.4 mM of malcate solution in phosphau saline buffer pH 7.4 
(6.16 mM KCI. I54 mM NaCI. 1.65 mM NaHPO,. 9.35 n1M 
&HPO,, pH 7:4), and 8 animal; with 0.2 ml of 6.4 m-M chlorphe- 
niramine (maleate salt) solution in the same buffer. pH 7.4; (f)-chlor- 
pheniraminc was purchased from Sigma Quimica (Spain). Animals 
were sacrificed on the 7th and I It11 days after tumour transplantation 
by cervical dislocation. Immediately, cells were separated by zenlrifu- 
gation at 2,OOOxg for 5 min, frozen and stored until used at -20°C 
(ODC assay) or -80°C (total RNA isolation). Cell viability and the 
total number of turnour cells were determined by the erythrosine 
exclusion test. For synthesis and degradation experiments, cells were 
collected IO-1 I days after turnour transplantation and cultured in a 
I:I mixture of Ham’s F12 and Dulbecco’s Mod&d Eagle’s medium 
supplemented with 0,2% bovine serum albumin and antibiotic (50 
Il_J/ml penicillin and 50 bg/ml streptomycin) at 37°C and 5% of CO:. 
After 4 I1 of culture, (?r)-chlorpheniramine ~2s added to different 
concentrations, and cells were further cultured and collected 4h later. 
In control samples. the antihistaminic addition was replaced by the 
culture medium. 
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2.2. ODC mRNA levels 
ODC mRNA was dclcrmined by Northern blot analysis. Total 
RNA (IO pg), isolated as described by Chomczgnski and Sacchi [13], 
was fractionated as described by Lchrach et al. [14] in formaldchyde- 
containing I .4% agarosc gcls(2.2 M formaldehyde). After being trans- 
ferred to S&S NYTRAN nylon membranes (Scbleichcr and Schucll 
Inc., Germany), the RNA was hybridizd to the ODC cDNA insert 
of the clone pODC934 [IS] labellcd by Multiprime DNA Labclling 
System with [~z-~?P]~CTP (Amcrsham Ibcrica, Spain). As an internal 
standard, mRNA for glyceraldchyde-3-phosphate dchydrogenasc 
(GAPDH) was detected [16], using a 1.3 kb GAPDH cDNA cloned 
in pUC9 (obtained by Dr. Bos, State University of Leiden, and kindly 
provided by Dr. van Stcq, National lnslitule of Public Health and 
EnvironmenIal protection, Tbe Netherlands). Autoradiographs were 
analyzed by transmiltancc densitometry. using a Hoeffcr GS 300 scan- 
ning denshomewr (Hoeffer Scientific, USA). 
2.3. ODC sytrltcws, dqyadutior~ attd ociivir) 
After 8 h of culture, cells were collected by cenlrifugiilion. They 
were resuspended ii1 4 x 10’ cells/ml in growth medium lacking 
methionine and prcincubatcd for 5-10 min at 37°C. Then, 2OO@lml 
Tran”Slabel (ICN, USA) was added and cells were incubuled fol 
different times up to 30 min. The incorporation of radiolabel into 
protein was stopped and cell extracts were obtained as described by 
Wallon et al. [l7]. Duplicates of 2 ~1 from each ccl! extract were 
prccipilnled using final 10% (w/w) trichloroacetic acid, and Altered as 
described by Helm et al. [5]; and the acid-insoluble radioactivity was 
counlcd. Total protein synthesis rate is the slope obtained after repre- 
seming the I’S incorpotxlion into acid-insoluble fraclion (cpm)&g of 
extract protein versus labclling time (min). For measuring rclativc 
ODC synthesis. aliquots of the supernatam (containing equal amounts 
of acid-insoluble radioactivity) were incubated with an excess of poly- 
clonal monospecific anlibody raised againsl mouse ODC (kindly pro- 
vided by Dr. Persson. Univershy of Lund, Sweden). The ODC-anti- 
body complex was collected by precipitation with insalublc Protein 
A [5.17]. Proteins were separated by SDS-PAGE nnd visualized by 
fluorography using EN”HANCE (Du Pant, USA). A 53 kDa band 
(ODC) was dcteclable when using specific ODC-anlibodies. but h was 
absent in lanes loaded with parallel samples treated with non-immune 
rabbit serum. Gel lanes were cut from 50-55 kDa and counted fol 
radioactivity (cpm incorporaled in ODC). Non-immune serum treated 
lanes were used as blanks. R&live ODC synhcsis is expressed as 
(cpm incorporated in ODC/tc&tl cpm used for immunoprecipitation) 
x 100. The half-life of ODC was determined by measuring the decline 
in enzyme aaivity after adding 50 ,f@ml of cyclohcximide to the 
medium aTter the 8th hour of culture [17]. Ornithinc decarboxylasc 
irssays were carried out as reported previously by Mat& et al. [IO.1 I]. 
3. RESULTS 
Fig. 1 A shows the evolution of the Lotal body weight 
of non-treated inoculated animals. The weight increase 
correlates to total tumour volume [18]. Tumour prolif- 
eration has a 3-day lag phase afkr inoculation into 
animals; seven days after transplantation, cells are in 
the exponential phase of growth, and the maximum 
number of intact cells occurred between the 9th and the 
11 th day after tumour inoculation [I$)]. Commercial 
(A)-chlorpheniramine is available as maleate salt; thus, 
groups of control ahimals were treated with daily i.p. 
injections of 0.75 mg of maleic acid neutralized at pH 
7.4. Maleate had no effect on the evolution of total 
animal weight, tumor proliferation and animal life span 
(16 k 1 day), neither when injected from day three after 
tumour inoculation (Fig. 1A) nor when injected from 
LV * 
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Fig. I. Evolulion of total body weight of animals inoculated with 
Ehrlich ascitic carcinoma. A: non-treated animals (0. and animals 
trcatcd daily with 0.75 mg of neutralized malcic acid (u); B: (+)- 
chlorphcniraminc trealed animals, 0.2 m&/day (.I’& 0.5 m&lday (c), 
and I.5 mdday (0). 
the first day on. Daily i.p. injections of 1.52 mdday of 
(+)- chlorpheniramine starting from day 3 after inocula- 
tion had no effect on the total body weight of tumour- 
bearing mice, but led to a shortage in the animal life 
span (14 -t- I day). In contrast, lower i.p. doses 0.2-0.5 
mg/day of the antihistamine significantly reduced ani- 
mal body weight during the second part of the tumour 
progression (Fig. 1B). However, the life-span values 
(17 2 2 days) were not significantly different from those 
of maleale-treated controls. Similar results were ob- 
tained when animals were treated with equal doses of 
chlorpheniramine from the first day after tumour trans- 
plantation (results not shown). 
The differences observed in total animal weights be- 
tween maleate- and chlorpheniramine-treated animals 
clearly matched those in ascitic fluid volume and total 
cell number (Table I). Cell viability was the same in 
chlorpheniramine-treated and control animals. How- 
ever, the increase in the tumour cell number observed 
in control mice from day 7 to day 11 after tumor inoc- 
ulation [l S] is avoided in chlorpheniramine-treated ani- 
mals (0.5 mg/day, starting from day 3 after turnour 
inoculation). The maximum QDC activity in Ehrlich 
ascitic carcinoma growing ‘in vivo’ is detected at day 7 
[20]; (f)-chlorpheniramine was able to reduce this ‘in 
vivo’ ODC induction by 70% (Table I). However, at day 
1 I after tumour inoculation, when tumour growth has 
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Fig. 2. RNA blot analysis of ODC mRNAs of Ehrlich tumour cell 
growing in vivo. (A) day 7, and (B) day I I after iumour inoculation. 
Expcrimrntal conditions are explained in scvrtion 2: (M) RNA ol’cclls 
growing in malca:e-lreaicd animals; (C) RNA of cells growing in 
chlorpheniraminc-treated animals from day 3 after tumour inocula- 
tion. The signal for control mRNA (GAPDH) is shown below each 
ODC aulortidiogram. and it was obtained by rrhybridization of the 
same filter. 
stopped and ODC is the lowest detected ‘in vivo’ 
[19,X$ the antihistamine had a very weak effect. 
ODC induction by natural growth stimuli is related 
to increased transcription and translation rates of their 
Table 1 
Total tumour cells, ascitic fluid volume and total tumour ODCactivity 
in mice trcaled aily with 0.2 mg of maleaic (control) or 0.5 mg of 
(f)-chlorphcniramine from day 3 uftcr tumour inoculation 
Parameters Control (+)-chlorphc- 
niraminc 
Total tumour cells (IO” cells) 
Day 7 
Day II 
992+-93 lOl3?9G 
1857 k 175 975 2 148’ 
Ascitic fluid volume (ml) 
Day 7 I.93 +- 0.19 2.13 kO.26 
Day I I 7.04 ? 0.47 4.29 ? 0.7 I** 
Total tumour ODC activity (nmol CO&) 
Day 7 10.49 +- 2.99 2.99 2 0.5 I* 
Day I I 4.38 f I.04 I .8 I P 0.36’ 
The Mann-Whitney U non-parametric test was used to estimate the 
dcprec of statistical signikancc. 
*k0.005 vs. maleale control values 
a*PcO.OI vs. malcatc control values 
r 
50 100 250 
[(*I - chlorphenirornine] added 
to medium (,uM) 
Fig. 3. Elkct of(f).chlorphcniraminu on the ODC activity ofculturcd 
Ehrlich carcinoma cells. At 4 h after seeding, chlorpheniramine was 
added to cultures reaching final concentrations of 50. 100 and 250yM. 
Cells were further cultured for 4 h, and then removed for ODC activity 
assays. Results are expressed as the percentage of ODC activity in 
respect to control cultures (without chlorpheniraminc added). Data 
are mean of4 different assays + S.E.M. 
mRNAs [Z-4]. Since chlorpheniramine showed a more 
marked effect on ODC during the ‘in viva’ exponential 
phase of growth, the effect of the antihistamine on the 
tumor ODC mRNA levels was tested. A representative 
result is shown in Fig. 2. The signal intensities for ODC 
mRNA versus control mRNA calculated from several 
Northern blot experiments did not show differences in 
ODC mRNA levels between controls and chlorphe- 
niramine treated animals at day 7 or 11 after tumour 
transplantation. 
The effect of the antihistamine on the ODC synthesis 
and degradation was tested on Ehrlich cultured cells. 
Control cells were maintained for 8 h in serum-free 
medium. After this time, ODC activity (0.35 1: 0.09 
nmol CO,/h/lO” c&j w&s IG4-fold induced with respect 
to seeded cells. The presence of 50-250 PM (c)-chlor- 
pheniramine from the 4th hour of culture (lag phase of 
growth) to the 8th hour (the beginning of the exponen- 
tial phase of growth) led to a marked reduction in the 
ODC activity ranking from 50-80% of the control val- 
ues (Fig. 3). The estimated ODC half-life values were 
very similar for controls and 250,~M chlorpheniramine- 
treated cultures. After 4 h of treatment, 250 ,uM (?)- 
chlorpheniramine did not affect either total protein con- 
tent or total protein synthesis rate. However, differences 
are observed in specific 35S incorporation into ODC 
between controls and chlorpheniramine treated cultures 
(Table II). As Heby and Persson pointed out, ODC 
protein represents a minimum percentage of the total 
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protein content [l]. The decrease in reiati,ve ODC syn- 
thesis caused by 250 ,uM chlorpheniramine agreed with 
the observed ecrease in ODC activity (Fig. 3). 
4. DISCUSSION 
The present work validates results obtained from 
chlorpheniramine with perifused turnout- cells [ 111. In 
previous works, it was suggested that histamine and 
other 1,4-diamines, at micromolar concentrations, 
mimic the effect of natural polyamines uppressing the 
ODC induction caused by ornithine in pcrifused Ehrlich 
ascites tumour cells; these l,&diamines were more effec- 
tive for ODC induction inhibition than other amines 
having I ,3- and 1,5-diamine structures [lO,l 11. Multiple 
mechanisms have been proposed to take place during 
the ODC feedback regulation by natural polyamines: 
inhibition of the protein synthesis initiation and/or elon- 
gation [5,21], increase in ODC inactivation and/or deg- 
radation [6,22], and induction of antizyme [23]. Never- 
theless, Kahana and Nathans conclude that these effects 
are not specific for polyamines, other diamines are also 
able to mimic natural polyamines inhibiting ODC syn- 
thesis [S]. 
In agreement with the mechanism proposed for other 
diamines, the inhibitory effect of chlorpheniramine 
must be related to post-transcriptional regulatory mech- 
anisms, since ODC mRNA levels were not changed by 
chlorpheniramine. The results obtained after inhibition 
of protein synthesis with cycloheximide do not support 
an effect of (zh)-chlorpheniramine on ODC degradation. 
In this sense, chlorpheniramine differs from natural pol- 
yamines when used at micromolar ange concentration 
on culture cells [5,6]. However, results obtained from 35S 
Table 11 
Changes in cell viability. total protein content and synthesis, and 
ornithine dccarboxylasc half lift and synthesis caused by 250 PM 
(&)chlorpheniraminc in Ehrlich cultured cells after 4 h of treatment 
Parameters 
% Cell viability 
Total protein content 
(/@lo” cells) 
Total protein synthesis rate” 
(cpmlpg prot./min) 
ODC half lifeb 
(mm) 
Relative ODC synthesis (%) 
20 min labclling 
30 min labelling 
Control (2).chlorphe- Effect 
niramine (8) 
88.3 1 26 53.3 t 3.6 94 
272 r 33 281 ?I 20 103 
1389 1341 97 
(r = 0.96) (r=0.99) 
49 II0 
(r = -0.96) (r = -~~51 
5.59 x lO-J 0.96 x IO-’ I7 
3.65 x IO-” I.61 x IO-” 44 
r = correlation coefhcicnt obtained from linear regression analysis. 
d Measured by the radiolabel incorporation in total extract protein, 
“Obtained after representing the percentage ofODC activity remain- 
ing vs. time. 
’ Ornithinc decarboxylase ynthesis is expressed as the percentage of
the specific radiolubcl incorporation in ODC relative to the total 
protein synthesis (see section 2 for details). 
incorporation seem to indicate that chlorpheniramine 
inhibits the ODC induction by affecting specifically de 
novo synthesis of the enzyme, as natural polyamines do 
at translational level [5,8,17]. 
On the other hand, the shortage in life-span caused 
by higher doses of chlorpheniramine could be related to 
secondary effects of the antihistaminic on the host: de- 
crease in vascular permeability and immunosuppressor 
[24,X]. In spite of the secondary effects reported for the 
antagonists of HI-receptors, these data could be useful 
for the design of new and less toxic histamine analogs 
[26] with inhibitory effects on ODC. Actually, treatment 
with histamine or serotonin has an inhibitory effect on 
the progression of several experimental nd human tu- 
mors [24,27]. The delay between the inhibition of ODC 
by chlorpheniramine and the reduction of tumour 
growth agrees with data reported by other authors for 
this and other tumour models, since the treatment with 
an ODC inhibitor induces multiple compensatory 
mechanisms in polyamine uptake and biosynthesis 
[28,29]. Nevertheless, the characterization of ODC in- 
hibitors is interesting not only for therapeutic purposes, 
but they are also considered valuable tools in basic 
Sciences 1301. 
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